GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » EV-to-EBITDA

WIN-Partners Co (TSE:3183) EV-to-EBITDA : 6.62 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, WIN-Partners Co's enterprise value is 円16,159 Mil. WIN-Partners Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,441 Mil. Therefore, WIN-Partners Co's EV-to-EBITDA for today is 6.62.

The historical rank and industry rank for WIN-Partners Co's EV-to-EBITDA or its related term are showing as below:

TSE:3183' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.17   Med: 6.7   Max: 14.6
Current: 6.62

During the past 13 years, the highest EV-to-EBITDA of WIN-Partners Co was 14.60. The lowest was 2.17. And the median was 6.70.

TSE:3183's EV-to-EBITDA is ranked better than
66.67% of 81 companies
in the Medical Distribution industry
Industry Median: 10.06 vs TSE:3183: 6.62

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), WIN-Partners Co's stock price is 円1155.00. WIN-Partners Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円59.506. Therefore, WIN-Partners Co's PE Ratio for today is 19.41.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


WIN-Partners Co EV-to-EBITDA Historical Data

The historical data trend for WIN-Partners Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co EV-to-EBITDA Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.97 3.74 5.34 4.55 3.89

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.93 3.89 4.55 4.97 7.10

Competitive Comparison of WIN-Partners Co's EV-to-EBITDA

For the Medical Distribution subindustry, WIN-Partners Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's EV-to-EBITDA falls into.



WIN-Partners Co EV-to-EBITDA Calculation

WIN-Partners Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=16158.980/2440.651
=6.62

WIN-Partners Co's current Enterprise Value is 円16,159 Mil.
WIN-Partners Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,441 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WIN-Partners Co  (TSE:3183) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

WIN-Partners Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1155.00/59.506
=19.41

WIN-Partners Co's share price for today is 円1155.00.
WIN-Partners Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円59.506.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


WIN-Partners Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines